Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 93.67% is 27% above its 5-year average of 73.98%, around the middle of its 5-year range (-348.37%–630.27%).
17.30% above its 12-month average of 79.86%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 74.87%.
GROSS MARGIN
93.67%
GROSS MARGIN AVG TTM
79.86%
GROSS MARGIN AVG 3Y
71.38%
GROSS MARGIN AVG 5Y
73.98%
GROSS MARGIN AVG 10Y
86.99%
GROSS MARGIN AVG 15Y
76.39%
GROSS MARGIN AVG 20Y
78.85%
CURRENT VS TTM AVG
+17.30%
CURRENT VS 3Y AVG
+31.23%
CURRENT VS 5Y AVG
+26.61%
CURRENT VS 10Y AVG
+7.68%
CURRENT VS 15Y AVG
+22.63%
CURRENT VS 20Y AVG
+18.79%
SECTOR MEDIAN · HEALTHCARE
39.56%
median of 701 covered companies
CURRENT VS SECTOR MEDIAN
+136.78%
vs the sector median at left
Market Cap
$1.86B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
22.32%
5Y Avg
30.29%
Market Cap
$1.89B
Gross Margin
64.48%
TTM Avg
64.91%
3Y Avg
63.02%
5Y Avg
55.66%
Market Cap
$1.89B
Gross Margin
78.67%
TTM Avg
83.63%
3Y Avg
79.97%
5Y Avg
53.31%
Market Cap
$1.84B
Gross Margin
9.22%
TTM Avg
11.32%
3Y Avg
13.89%
5Y Avg
14.07%
Market Cap
$1.84B
Gross Margin
-319.36%
TTM Avg
-798.46%
3Y Avg
-813.46%
5Y Avg
-704.28%
Market Cap
$1.82B
Gross Margin
72.90%
TTM Avg
70.08%
3Y Avg
67.68%
5Y Avg
66.96%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novavax, Inc. (NVAX) | $1.88B | 93.67% | 79.86% | 71.38% | 73.98% |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.86B | 0.00% | 0.00% | 22.32% | 30.29% |
| Azenta, Inc. (AZTA)vs › | $1.88B | 44.05% | 44.96% | 41.63% | 40.93% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 64.48% | 64.91% | 63.02% | 55.66% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.89B | 78.67% | 83.63% | 79.97% | 53.31% |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 9.22% | 11.32% | 13.89% | 14.07% |
| Novocure Ltd (NVCR)vs › | $1.84B | 76.13% | 75.94% | 76.33% | 77.05% |
| Absci Corporation (ABSI)vs › | $1.84B | -319.36% | -798.46% | -813.46% | -704.28% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 72.90% | 70.08% | 67.68% | 66.96% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.94B | 70.49% | 67.64% | 66.50% | 65.90% |
Gross Margin
93.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 74.87% |
| 2026-03-31 | 78.00% |
| 2025-12-31 | 82.87% |
| 2025-09-30 | 69.49% |
| 2025-06-30 | 94.05% |
| 2025-03-31 | 97.88% |
| 2024-12-31 | 58.48% |
| 2024-09-30 | 28.27% |
| 2024-06-30 | 88.87% |
| 2024-03-31 | 48.00% |
| 2023-12-31 | 48.90% |
| 2023-09-30 | -348.37% |
| 2023-06-30 | 86.86% |
| 2023-03-31 | 630.27% |
| 2022-12-31 | 36.85% |
| 2022-09-30 | 40.84% |
| 2022-06-30 | -45.80% |
| 2022-03-31 | 97.49% |
| 2021-12-31 | 100.00% |
| 2021-09-30 | 100.00% |
| 2021-06-30 | 100.00% |
| 2021-03-31 | 100.00% |
| 2020-12-31 | 100.00% |
| 2020-09-30 | 100.00% |
| 2020-06-30 | 100.00% |
| 2020-03-31 | 100.00% |
| 2019-12-31 | 100.00% |
| 2019-09-30 | 100.00% |
| 2019-06-30 | 100.00% |
| 2019-03-31 | 100.00% |
| 2018-12-31 | 100.00% |
| 2018-09-30 | 100.00% |
| 2018-06-30 | 100.00% |
| 2018-03-31 | 100.00% |
| 2017-12-31 | -376.91% |
| 2017-09-30 | 100.00% |
| 2017-06-30 | 100.00% |
| 2017-03-31 | 100.00% |
| 2016-12-31 | -846.47% |
| 2016-09-30 | 100.00% |
| 2016-06-30 | 100.00% |
| 2016-03-31 | 100.00% |
| 2015-12-31 | -34.85% |
| 2015-09-30 | 57.90% |
| 2015-06-30 | 80.80% |
| 2015-03-31 | 75.10% |
| 2014-12-31 | 57.81% |
| 2014-09-30 | 50.97% |
| 2014-06-30 | 38.22% |
| 2014-03-31 | 59.51% |
| 2013-12-31 | 70.24% |
| 2013-09-30 | 52.60% |
| 2013-06-30 | 53.78% |
| 2013-03-31 | 55.34% |
| 2012-12-31 | 57.25% |
| 2012-09-30 | 33.43% |
| 2012-06-30 | 27.95% |
| 2012-03-31 | 18.44% |
| 2011-12-31 | -19.81% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 100.00% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 100.00% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | 100.00% |
| 2009-09-30 | 100.00% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 100.00% |
| 2008-06-30 | 100.00% |
| 2008-03-31 | 100.00% |
| 2007-12-31 | -384.58% |
| 2007-09-30 | 16.65% |
| 2007-06-30 | -441.14% |
| 2007-03-31 | -110.18% |
| 2006-12-31 | -115.80% |
| 2006-09-30 | 1.93% |
| 2006-06-30 | -38.38% |
| 2006-03-31 | -18.80% |
| 2005-12-31 | 68.05% |
| 2005-09-30 | 42.80% |
| 2005-06-30 | 12.44% |
| 2005-03-31 | -105.72% |
| 2004-12-31 | 33.43% |
| 2004-09-30 | 44.26% |
| 2004-06-30 | 50.05% |
| 2004-03-31 | 91.83% |
| 2003-12-31 | 83.37% |
| 2003-09-30 | 82.17% |
| 2003-06-30 | 82.95% |
| 2003-03-31 | 80.40% |
| 2002-12-31 | 56.97% |
| 2002-09-30 | 69.11% |
